1. |
Strykowski R, Adegunsoye A. Idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. Immunol Allergy Clin North Am, 2023, 43(2): 209-228.
|
2. |
Amaral AF, Colares PFB, Kairalla RA. Idiopathic pulmonary fibrosis: current diagnosis and treatment. J Bras Pneumol, 2023, 49(4): e20230085.
|
3. |
Zhao L, Zhou X, Xie F, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond), 2022, 42(2): 88-116.
|
4. |
Qi J, Kim JW, Zhou Z, et al. Ferroptosis affects the progression of nonalcoholic steatohepatitis via the modulation of lipid peroxidation-mediated cell death in mice. Am J Pathol, 2020, 190(1): 68-81.
|
5. |
Pei Z, Qin Y, Fu X, et al. Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model. Redox Biol, 2022, 57: 102509.
|
6. |
Jiao Y, Huang B, Chen Y, et al. Integrated analyses reveal overexpressed notch1 promoting porcine satellite cells’ proliferation through regulating the cell cycle. Int J Mol Sci, 2018, 19(1): 271.
|
7. |
Zhao N, Yan QW, Xia J, et al. Treadmill exercise attenuates Aβ-induced mitochondrial dysfunction and enhances mitophagy activity in APP/PS1 transgenic mice. Neurochem Res, 2020, 45(5): 1202-1214.
|
8. |
Zheng D, Liu J, Piao H, et al. ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol, 2022, 13: 1039241.
|
9. |
Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J, 2022, 289(22): 7038-7050.
|
10. |
Gao X, Hu W, Qian D, et al. The mechanisms of ferroptosis under hypoxia. Cell Mol Neurobiol, 2023, 43(7): 3329-3341.
|
11. |
Erdélyi K, Ditrói T, Johansson HJ, et al. Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation. Proc Natl Acad Sci U S A, 2021, 118(45): e2100050118.
|
12. |
Yang Y, Hong S, Lu Y, et al. CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis. PeerJ, 2022, 10: e14033.
|
13. |
Vaz de Paula CB, Nagashima S, Liberalesso V, et al. COVID-19: immunohistochemical analysis of TGF-β signaling pathways in pulmonary fibrosis. Int J Mol Sci, 2021, 23(1): 168.
|
14. |
He R, Yuan X, Lv X, et al. Caveolin-1 negatively regulates inflammation and fibrosis in silicosis. J Cell Mol Med, 2022, 26(1): 99-107.
|
15. |
Qu L, Li Y, Chen C, et al. Caveolin-1 identified as a key mediator of acute lung injury using bioinformatics and functional research. Cell Death Dis, 2022, 13(8): 686.
|
16. |
He J, Li X. Identification and validation of aging-related genes in idiopathic pulmonary fibrosis. Front Genet, 2022, 13: 780010.
|
17. |
Gungor H, Ekici M, Onder Karayigit M, et al. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393(9): 1659-1670.
|
18. |
Felix RG, Bovolato ALC, Cotrim OS, et al. Adipose-derived stem cells and adipose-derived stem cell-conditioned medium modulate in situ imbalance between collagen I- and collagen V-mediated IL-17 immune response recovering bleomycin pulmonary fibrosis. Histol Histopathol, 2020, 35(3): 289-301.
|
19. |
Siddiqui JA, Pothuraju R, Khan P, et al. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia. Cytokine Growth Factor Rev, 2022, 64: 71-83.
|
20. |
Park MR, Wong MS, Araúzo-Bravo MJ, et al. Oct4 and Hnf4α-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model. PLoS One, 2019, 14(8): e0221085.
|